![Research report: [18F]FDG PET/CT imaging of the metabolic response in advanced breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors](https://bioengineer.org/wp-content/uploads/2026/11/stackrss-featured-3094-350x250.jpg)
Research report: [18F]FDG PET/CT imaging of the metabolic response in advanced breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors
A study in Breast Cancer Research found that metabolic response measured by FDG-PET/CT is associated with longer progression-free survival in ...
